The Lib Narrative About the Minneapolis ICE Shooting Took Another Brutal Hit
Reconciliation 2.0 Has Arrived
Here's the Anti-Trump FBI Agent Who Launched the Surveillance Probe of the Entire...
A CNN Guest Got Way Ahead of Her Skis Over This Claim About...
Tim Walz Just Did a Major Flip-Flop on This Minnesota U.S. Attorney
The Latest Update Out of Iran As Regime Attempts to Squash Uprising Will...
U.S. Sees Net Negative Migration for the First Time in Decades
After Democrat Smears, Tom Homan Confirmed ICE Agent and Family Were Forced to...
This Is What's at Stake As SCOTUS Mulls the Issue of Men in...
Cut Them Off NOW!
The Prime of Tough-Guy Progressivism
Minneapolis Mayor Jacob Frey Shrugs Off Assaults on ICE Agents: They Are Standing...
ACLU Lawyer Stumped When Justice Alito Asks for the Definition of Man and...
Watch: Woman Dragged Out of Car by ICE After Impeding Enforcement Operations in...
Time to Crack Down on Fraud
Tipsheet

Media Outlets Openly Report That the FDA's Latest Decision Was Political

The Food and Drug Administration on Thursday approved the first over-the-counter birth control pill in the U.S.

In early 2024, Perrigo’s once-a-day Opill, a progestin-only pill, will be available at drug stores, supermarkets, and online.

Advertisement

“Today’s approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research, on Thursday. “When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy.”

There is no age restriction on the pill, despite concerns over correct usage and possible health hazards associated with it.

Seventeen advisers to the FDA voted unanimously in May to make Opill available over the counter despite concerns the agency raised about data Perrigo submitted with its application, including a study showing that many participants reported taking more pills than they were dispensed. The company said it couldn’t explain the discrepancy.

The agency questioned whether younger people and people with limited literacy could follow the dosing directions and said researchers likely used methods that exaggerated positive results. Perrigo said standards met or exceeded those used in other studies exploring over-the-counter drug adherence. (WSJ)

Kristan Hawkins of Students for Life said the news should mean pro-choice advocates won’t need abortions anymore, according to their own arguments. 

Advertisement

Related:

FDA

Others pointed out that media reports are not hiding the fact that it was a political decision. 

Health experts, citing the pill’s lengthy record of safety and effectiveness, have pushed for a nonprescription pill for years, but their campaign took on new urgency after the Supreme Court last year struck down the fundamental right to abortion established by Roe v. Wade. (WaPo)

Since the Supreme Court overturned the national right to an abortion last year, the accessibility of contraception has become an increasingly urgent issue. (NYT)

Though the drug itself and the campaign for its approval go back decades, pressure on the Biden administration to approve a hormonal over-the-counter birth control option increased after the fall of Roe v. Wade last year. (Politico)


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos